Olmesartan and Valsartan Anti-atherosclerosis Trial in Patients with Mild-Hypertension: Using Three-dimensional serial IVUS Study

Trial Profile

Olmesartan and Valsartan Anti-atherosclerosis Trial in Patients with Mild-Hypertension: Using Three-dimensional serial IVUS Study

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Valsartan
  • Indications Angina pectoris; Atherosclerosis; Hypertension
  • Focus Therapeutic Use
  • Acronyms OVATION
  • Most Recent Events

    • 07 Nov 2012 Results in 71 patients presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 04 Mar 2011 New trial record
    • 01 Oct 2010 Primary endpoint 'Plaque-volume' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top